Subscribe to Newsletter

November 2020 Issue of The Medicine Maker

In November’s issue of The Small Molecule Manufacturer, industry experts discuss best practices for handling HPAPIs in our cover feature. We also explore how 3D printing can be used to improve therapeutic options for the blind and visually impaired in the Next Big Thing, as well as how drug developers can best handle solubility-challenged molecules. And we sit down with Kimberly Eggers, Vice-president of Medical and Clinical Affairs at Aprecia, who explains how the COVID-19 pandemic has affected her first year at the company.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Other issues of 2020